Crural Dissection in Sleeve Gastrectomy
Launched by UNIVERSITY OF MIAMI · Nov 15, 2019
Trial Information
Current as of August 24, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • 1. All patients undergoing primary sleeve gastrectomy at the University of Miami Division of Bariatric surgery
- • 2. Age between 18-69 years
- • 3. Able to provide consent
- Exclusion criteria:
- • 1. History of anti-reflux procedure
- • 2. History of foregut surgery
- • 3. Narcotic dependence
- • 4. History of gastroparesis
- • 5. Special/vulnerable populations such as minors, patients unable to consent, pregnant women, and prisoners will not be included in the study
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Nestor De La Cruz-Munoz, MD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials